Financial Daily from THE HINDU group of publications
Thursday, Nov 25, 2004
Financial Daily from THE HINDU group of publications Thursday, Nov 25, 2004 |
|
|
|
|
|
Corporate
-
Alliances & Joint Ventures Panacea ties up with Chiron Our Bureau
Mumbai , Nov. 24 THE New Delhi-based Panacea Biotec Ltd has entered into a joint-venture with the UK-based Chiron Vaccines to provide new generation combination vaccines. Chiron Panacea Vaccines, the 50:50 joint-venture company, will get operationalised on a seed capital of $1 million that has been invested by both companies, said Mr Rajesh Jain, Joint Managing Director, Panacea Biotec. Speaking at the launch of the venture, he said that the company would kick-off with an initial portfolio of vaccines, at prices that were competitive. "We are not saying that the vaccines will be cheap, but it will be a comprehensive combination vaccine portfolio from a single company and we are adopting a differentiation strategy to increase market-share," he said. The product portfolio largely targets the private practitioners and the vaccines will be manufactured by Panacea at it's plants in India.
More Stories on : Alliances & Joint Ventures | Bio-tech & Genetics
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|